HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.

Abstract
We studied two women with severe hypotonic polyuria whose symptoms dated from infancy. We eliminated the possibility of central diabetes insipidus (DI) and primary polydipsia, and established the presence of nephrogenic DI on the basis of: 1) the interrelationships between plasma osmolality, urine osmolality, and urinary AVP; and 2) impaired antidiuretic responses to AVP and 1 deamino-8-D-arginine vasopressin. Though 25-50 times as resistant to 1 deamino-8-D-arginine vasopressin nasal spray as patients with central DI, these patients could be treated effectively with large doses of the nasal spray. One patient has been so treated for more than a year with dramatic improvement in her polydipsia, polyuria, and sense of well-being.
AuthorsA M Moses, S J Scheinman, A Oppenheim
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 59 Issue 6 Pg. 1044-9 (Dec 1984) ISSN: 0021-972X [Print] United States
PMID6490792 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Arginine Vasopressin
  • Deamino Arginine Vasopressin
Topics
  • Administration, Intranasal
  • Adult
  • Arginine Vasopressin (metabolism, therapeutic use)
  • Deamino Arginine Vasopressin (administration & dosage, therapeutic use)
  • Diabetes Insipidus (complications, drug therapy)
  • Drug Resistance
  • Female
  • Humans
  • Kidney Concentrating Ability (drug effects)
  • Kidney Diseases (complications, drug therapy)
  • Polyuria (etiology)
  • Thirst

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: